GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93023C00048INSTITUT DE FORMULATION DES VACCINS (CH) SA

Overview

Award facts

Net obligations
$8.19M
$8,193,365of $8.19M potential value
Outlays (paid to date)
$5.17M
$5.17M paid of $8.19M obligated$5,174,605
Period of performance
Sep 30, 2023 to Sep 30, 2027
Ends in 10 months
Modifications
6
Latest action Sep 14, 2026
Contract type
Definitive contract
PIID 75N93023C00048

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES

Dates and value

Award date
Signed on Sep 12, 2023
Potential end of performance
Sep 29, 2028
Current value
$8,193,365Base and exercised options
Potential value (if all options are exercised)
$8,193,365

Obligations by fiscal year of action

  • FY2026: $1,256,247
  • FY2025: $2,000,000
  • FY2024: $3,488,070
  • FY2023: $1,449,048

Total across 4 fiscal years: $8,193,365

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 14, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationPLAN-LES-OUATES, CHE
UEIN773KSZMJA78
CAGE codeSMVP9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationLimited liability companyTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Switzerland

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
24

Solicitation and notices

Solicitation ID
75N93022R00009(as reported)
Solicitation date
Apr 13, 2022

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 12, 2023Base obligation at award: $1,449,048
Latest action
Sep 14, 2026 — Option exercisedModification P00006; obligation change +$1,256,273
Latest substantive action
Sep 14, 2026 — Option exercisedModification P00006; obligation change +$1,256,273
Latest funding action
Apr 24, 2026 — Funding onlyModification P00005; obligation change -$26; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Change order2
  • Option exercised2
  • Funding only1
  • Other administrative action1
7 actions recorded, Sep 12, 2023 to Sep 14, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$1,256,273
Latest action: change in base and all options
$1,256,273

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
SwitzerlandCHE
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$143,973
COVID-19 supplemental outlays
$143,973